• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抗精神病药物与躯体共病:一项针对城市门诊精神科诊所的回顾性研究。

Antipsychotics and Medical Comorbidity: A Retrospective Study in an Urban Outpatient Psychiatry Clinic.

作者信息

Bennett Catherine W, Gensler Lauren, Goldsmith David R

机构信息

Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, 12 Executive Park Drive, Suite 331K, Atlanta, GA, 30329, USA.

Department of Medicine, Emory University School of Medicine, Atlanta, GA, USA.

出版信息

Community Ment Health J. 2023 May;59(4):641-653. doi: 10.1007/s10597-022-01045-2. Epub 2022 Nov 10.

DOI:10.1007/s10597-022-01045-2
PMID:36355255
Abstract

Patients with psychotic disorders have increased rates of medical comorbidities. In this cross-sectional study, we investigated the relationship between antipsychotics and medical comorbidities among patients with psychotic disorders in an urban psychiatry clinic in Atlanta, Georgia (n = 860). Each antipsychotic group was compared to a group of patients from the same sample who were not on any antipsychotic, and logistic regression models were constructed for each comorbidity. Ziprasidone was associated with diabetes (aOR 2.56, 95% CI 1.03-6.38) and obesity (aOR 3.19, 95% CI 1.37-7.41). Aripiprazole was associated with obesity (aOR 2.39, 95% CI 1.27-4.51). Clozapine was associated with GERD (aOR 3.59, 95% CI 1.11-11.61), movement disorders (aOR 4.44, 95% CI 1.02-19.32), and arrythmias (4.89, 95% CI 1.44-16.64). Two antipsychotics that are considered weight neutral, ziprasidone and aripiprazole, were associated with cardiometabolic comorbidities. This study suggests that research is warranted to study the association between antipsychotics, medical comorbidity, and psychotic symptom burden.

摘要

患有精神障碍的患者合并其他疾病的几率更高。在这项横断面研究中,我们调查了佐治亚州亚特兰大市一家城市精神病诊所中患有精神障碍的患者使用抗精神病药物与合并其他疾病之间的关系(n = 860)。将每个抗精神病药物组与同一样本中未使用任何抗精神病药物的患者组进行比较,并针对每种合并症构建逻辑回归模型。齐拉西酮与糖尿病(调整后比值比2.56,95%置信区间1.03 - 6.38)和肥胖症(调整后比值比3.19,95%置信区间1.37 - 7.41)相关。阿立哌唑与肥胖症(调整后比值比2.39,95%置信区间1.27 - 4.51)相关。氯氮平与胃食管反流病(调整后比值比3.59,95%置信区间1.11 - 11.61)、运动障碍(调整后比值比4.44,95%置信区间1.02 - 19.32)和心律失常(调整后比值比4.89,95%置信区间1.44 - 16.64)相关。两种被认为对体重无影响的抗精神病药物,齐拉西酮和阿立哌唑,与心脏代谢合并症相关。这项研究表明,有必要开展研究以探讨抗精神病药物、合并其他疾病和精神症状负担之间的关联。

相似文献

1
Antipsychotics and Medical Comorbidity: A Retrospective Study in an Urban Outpatient Psychiatry Clinic.抗精神病药物与躯体共病:一项针对城市门诊精神科诊所的回顾性研究。
Community Ment Health J. 2023 May;59(4):641-653. doi: 10.1007/s10597-022-01045-2. Epub 2022 Nov 10.
2
An open, large, 6-month naturalistic study of outcome in schizophrenic outpatients, treated with olanzapine.一项针对使用奥氮平治疗的精神分裂症门诊患者结局的开放性、大型、为期6个月的自然主义研究。
Hum Psychopharmacol. 2011 Jan;26(1):81-5. doi: 10.1002/hup.1173. Epub 2011 Feb 9.
3
Using antipsychotic agents in older patients.在老年患者中使用抗精神病药物。
J Clin Psychiatry. 2004;65 Suppl 2:5-99; discussion 100-102; quiz 103-4.
4
Prevalence of antipsychotic prescriptions among patients with anxiety disorders treated in inpatient and outpatient psychiatric settings.在住院和门诊精神科环境中接受治疗的焦虑症患者中抗精神病药物处方的流行情况。
J Affect Disord. 2016 Feb;191:292-9. doi: 10.1016/j.jad.2015.11.031. Epub 2015 Nov 26.
5
The incidence of diabetes in atypical antipsychotic users differs according to agent--results from a multisite epidemiologic study.非典型抗精神病药物使用者中糖尿病的发病率因药物种类而异——一项多中心流行病学研究的结果
Pharmacoepidemiol Drug Saf. 2009 Sep;18(9):791-9. doi: 10.1002/pds.1781.
6
Letter to the Editor: Rethinking The Cost Of Antipsychotic Treatment: The Average Cost Of The Drugs Used In Turkey In 2020.给编辑的信:重新思考抗精神病药物治疗的成本:2020 年土耳其使用的药物的平均成本。
Turk Psikiyatri Derg. 2022 Summer;33(2):146-148. doi: 10.5080/u26315.
7
Second-generation (atypical) antipsychotics and metabolic effects: a comprehensive literature review.第二代(非典型)抗精神病药物与代谢效应:一项全面的文献综述
CNS Drugs. 2005;19 Suppl 1:1-93. doi: 10.2165/00023210-200519001-00001.
8
Does Switching Antipsychotics Ameliorate Weight Gain in Patients With Severe Mental Illness? A Systematic Review and Meta-analysis.换用抗精神病药能否改善重性精神疾病患者的体重增加?系统评价和荟萃分析。
Schizophr Bull. 2021 Jul 8;47(4):948-958. doi: 10.1093/schbul/sbaa191.
9
Rates of complete nonadherence among atypical antipsychotic drugs: A study using blood samples from 13,217 outpatients with psychotic disorders.非典型抗精神病药物完全不依从率:一项使用 13217 名精神疾病门诊患者血样的研究。
Schizophr Res. 2021 Feb;228:590-596. doi: 10.1016/j.schres.2020.11.025. Epub 2020 Nov 19.
10
Continuation of Atypical Antipsychotic Medication During Early Pregnancy and the Risk of Gestational Diabetes.继续使用非典型抗精神病药物治疗早孕与妊娠期糖尿病的风险。
Am J Psychiatry. 2018 Jun 1;175(6):564-574. doi: 10.1176/appi.ajp.2018.17040393. Epub 2018 May 7.

本文引用的文献

1
Selective serotonin reuptake inhibitors and risk reduction for cardiovascular disease in patients with schizophrenia: A controversial but promising approach.选择性5-羟色胺再摄取抑制剂与精神分裂症患者心血管疾病风险降低:一种有争议但有前景的方法。
World J Psychiatry. 2021 Jul 19;11(7):316-324. doi: 10.5498/wjp.v11.i7.316.
2
Pharmacological Management of Glucose Dysregulation in Patients Treated with Second-Generation Antipsychotics.第二代抗精神病药物治疗患者的血糖调节药物治疗。
Drugs. 2020 Nov;80(17):1763-1781. doi: 10.1007/s40265-020-01393-x.
3
Update on weight-gain caused by antipsychotics: a systematic review and meta-analysis.
抗精神病药引起的体重增加的最新进展:系统评价和荟萃分析。
Expert Opin Drug Saf. 2020 Mar;19(3):295-314. doi: 10.1080/14740338.2020.1713091. Epub 2020 Mar 12.
4
Long-term metabolic and cardiovascular effects of antipsychotic drugs. A meta-analysis of randomized controlled trials.抗精神病药物的长期代谢和心血管效应。一项随机对照试验的荟萃分析。
Eur Neuropsychopharmacol. 2020 Mar;32:56-65. doi: 10.1016/j.euroneuro.2019.12.118. Epub 2020 Jan 6.
5
Chronic inflammation in the etiology of disease across the life span.慢性炎症在整个生命周期疾病发病机制中的作用。
Nat Med. 2019 Dec;25(12):1822-1832. doi: 10.1038/s41591-019-0675-0. Epub 2019 Dec 5.
6
Clozapine associated pulmonary embolism: systematic review.氯氮平相关的肺栓塞:系统评价
J Community Hosp Intern Med Perspect. 2019 Sep 5;9(4):300-304. doi: 10.1080/20009666.2019.1627848. eCollection 2019.
7
Comorbidity of Physical Disorders Among Patients With Severe Mental Illness With and Without Substance Use Disorders: A Systematic Review and Meta-Analysis.患有和不患有物质使用障碍的严重精神疾病患者的躯体障碍共病情况:系统评价和荟萃分析。
J Dual Diagn. 2019 Jul-Sep;15(3):192-206. doi: 10.1080/15504263.2019.1619007. Epub 2019 Jun 4.
8
Association of Insulin Resistance With Schizophrenia Polygenic Risk Score and Response to Antipsychotic Treatment.胰岛素抵抗与精神分裂症多基因风险评分及抗精神病药物治疗反应的相关性。
JAMA Psychiatry. 2019 Aug 1;76(8):864-867. doi: 10.1001/jamapsychiatry.2019.0304.
9
Treatment Recommendations for Tardive Dyskinesia.迟发性运动障碍的治疗建议。
Can J Psychiatry. 2019 Jun;64(6):388-399. doi: 10.1177/0706743719828968. Epub 2019 Feb 21.
10
Efficacy, acceptability and tolerability of antipsychotics in patients with schizophrenia and comorbid substance use. A systematic review and meta-analysis.抗精神病药治疗精神分裂症合并物质使用障碍患者的疗效、可接受性和耐受性:系统评价和荟萃分析。
Eur Neuropsychopharmacol. 2019 Jan;29(1):32-45. doi: 10.1016/j.euroneuro.2018.11.1105. Epub 2018 Nov 22.